Industry Briefs: Mar. 26, 2012 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Industry Briefs: Mar. 26, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.

Company News

Corcept Therapeutics has selected PharmaForm as its primary commercial manufacturer for its newly approved drug product, Korlym (mifepristone) for treating Cushing’s syndrome. Read More

Coronado Biosciences has signed a collaboration agreement with Dr. Falk Pharma and OvaMed for the development of trichuris suis ova for treating Crohn’s Disease. Read More

Elite Pharmaceuticals has signed an agreement with a private Hong Kong-based company to develop a branded prescription pharmaceutical product in the US. Read More

GE Healthcare has expanded its Shanghai Fast Trak training center to serve the growing biopharmaceutical industry in China.

Impax and Tolmar have multiproduct agreement for the development, supply, and distribution of alternative dosage-form products. Read More

Marken has completed all commissioning work for its new operational hub in Feltham, United Kingdom. Read More

People News

Adhesives Research appointed Steven Herbert to the position of manufacturing manager.

Albany Molecular Research has named Stephen Rossmeis senior manager to oversee the company's facilities at Burlington, Massachusetts aseptic-fill operations. Read More

Avrio Biopharmaceuticals has appointed William P. Botha as president. Read More


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here